Peru vs Puerto Rico: The number of people with susceptibility test result for rifampicin
Peru
94.02
in 2021
Puerto Rico
93.33
in 2021
Peru rank
55th
Puerto Rico rank
58th
The number of people with susceptibility test result for rifampicin over time
- Peru
- Puerto Rico
How they compare
Peru currently reports 94.02 against 93.33 in Puerto Rico, a difference of 0.69.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Puerto Rico ahead.
Peru ranks 55th and Puerto Rico ranks 58th of 146 countries.
Puerto Rico has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Peru | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 76.94 | 97.81 | 20.87 | Puerto Rico |
| 2020s | 82.99 | 94.49 | 11.5 | Puerto Rico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Peru or Puerto Rico?
- Peru, at 94.02 against 93.33 in Puerto Rico as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Peru and Puerto Rico?
- 0.69, with Peru ahead.
- How many years of comparable data are there for Peru and Puerto Rico?
- 5 years are reported by both, from 2017 to 2021.
- How do Peru and Puerto Rico rank globally for the number of people with susceptibility test result for rifampicin?
- Peru ranks 55th and Puerto Rico ranks 58th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.